-- Abbisko (HKG:2256) said it was looking to raise nearly HK$523 million via a share offering, according to a Hong Kong bourse filing Tuesday.
The firm is seeking investors for 42.9 million shares priced at HK$12.18 each to raise funds for the research and development of cancer and non-cancer drug candidates.
The shares represent 6.37% of the company's issued share capital and 5.99% as enlarged by the sale.